Sitemap

April 16, 2008 Articles

Filter by Available Specialty
  1. Akorn receives FDA approval for ofloxacin ophthalmic solution
  2. Filling cortical defects after hardware removal may reduce re-fracture risk
  3. Good long-term results observed after surgically removing extensive peripapillary choroidal neovascularization
  4. Industry funding and conflicts of interest
  5. OptiMedica enters distribution agreement with Topcon Medical Japan
  6. Patients more likely to use insulin pens as a result of physician recommendation
  7. Reductions in corneal hysteresis appear similar after LASIK, LASEK
  8. Share control with the patient!
  9. Toremifene reduced fractures in androgen deprivation-treated prostate cancer
  10. Toremifene reduced fractures in androgen deprivation-treated prostate cancer
  11. Two phase-2 trials examine treatments for hepatocellular carcinoma